OraSure Reports Q2 ’24 Revenue of $54.3 Million
06 août 2024 16h05 HE
|
OraSure Technologies, Inc.
Q2 GAAP EPS of $(0.01); Q2 Non-GAAP EPS of $0.07 OraQuick® HCV Self-test is the first globally to earn WHO pre-qualification Strong momentum with Syphilis Health Check™ launch Expanding Sample...
OraSure to Announce Second Quarter 2024 Financial Results and Host Earnings Call on August 6th
22 juil. 2024 16h05 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering second quarter 2024 financial results and...
OraSure Technologies Supports National HIV Testing Day
27 juin 2024 07h05 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., June 27, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests and sample management solutions today announced its...
OraSure Reports Q1 ’24 Revenue of $54.1 Million
08 mai 2024 16h05 HE
|
OraSure Technologies, Inc.
Q1 GAAP EPS of $(0.05); Q1 Non-GAAP EPS of $0.04 Restructuring initiatives expected to result in $15 million of annualized expense reductions once fully implemented and position OraSure to achieve...
OraSure to Announce First Quarter 2024 Financial Results and Host Earnings Call on May 8th
22 avr. 2024 08h00 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., April 22, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering first quarter 2024 financial results and...
OraSure Reports Q4 ‘23 Revenue of $75.9 Million
27 févr. 2024 16h05 HE
|
OraSure Technologies, Inc.
Q4 GAAP EPS of $0.27; Q4 Non-GAAP EPS of $0.22 Grew cash balance to $290.4 million as of December 31, 2023 Enters U.S. Syphilis testing market via strategic distribution agreement with Diagnostics...
OraSure to Announce Fourth Quarter 2023 Financial Results and Host Earnings Call on February 27th
13 févr. 2024 16h05 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Feb. 13, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering fourth quarter 2023 financial results and...
OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests in Sapphiros, a Next-Generation Consumer Diagnostics Company
04 janv. 2024 07h05 HE
|
OraSure Technologies, Inc.
The relationship expands OraSure’s innovation pipeline with access to a broad portfolio of key Sapphiros products in development. Distribution of Sapphiros’ products is expected to accelerate...
OraSure to Participate in Upcoming Investor Conferences
13 nov. 2023 16h15 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Nov. 13, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome...
OraSure Reports Q3 ‘23 Revenue of $89.2 Million; Core Revenue Grows 7% Year-over-Year
07 nov. 2023 16h05 HE
|
OraSure Technologies, Inc.
Q3 GAAP EPS of $0.15; Q3 Non-GAAP EPS of $0.27 Grew cash balance to $224.9 million as of September 30, 2023 BETHLEHEM, Pa., Nov. 07, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:...